Research News for August 2012
-
Genes Associated with Breast Size Also Linked to Breast Cancer
A study found seven pieces of chromosomes that are associated with breast size; three of these also are associated with breast cancer.
-
Lack of Sleep Linked to Higher Risk of Recurrence of Estrogen-Receptor-Positive Disease in Postmenopausal Women
A small study suggests that not getting enough sleep may be linked to a higher recurrence risk for early-stage, estrogen-receptor-positive breast cancer in postmenopausal women.
-
Obese and Overweight Women May Have Higher Risk of Recurrence
A large study suggests that overweight and obese women diagnosed with early-stage, hormone-receptor-positive breast cancer have a higher risk of the cancer coming back and are less likely to survive the disease.
-
T-DM1 Improves Survival in Women with HER2-Positive Metastatic Breast Cancer
Women diagnosed with HER2-positive metastatic breast cancer lived longer when they got the experimental medicine T-DM1 compared to women who got a different targeted therapy regimen.
-
New Tool May Help Figure Out Which Older Women Can Skip Radiation After Lumpectomy
To help doctors better understand which older women can safely skip radiation therapy after lumpectomy, researchers have developed a new predictive tool.
-
Survey Says Women Want to See Reconstruction Results Before Breast Cancer Surgery
Survey results reveal that 89% of U.S. women diagnosed with breast cancer want to see what reconstruction results would look like before starting treatment.
-
Exercise Improves Quality of Life During and After Treatment
Two new, separate review studies found that 12 weeks of exercise was linked to better overall quality of life for people being treated for cancer as well as survivors.
-
Chemo During Pregnancy Appears Safe for Mother and Child
A study supports other research that suggests chemotherapy during pregnancy doesn't have harmful effects on the baby.
-
Xgeva Better Than Zometa at Reducing Risk of Bone Problems in Women with Metastatic Disease
Research suggests that Xgeva is better than Zometa at reducing the risk of bone complication and improves quality of life more in women diagnosed with metastatic breast cancer that has spread to the bones.
-
Docs Need to Consider Quality of Life When Assessing Lymphedema
A study strongly suggests that considering a person's quality of life as well as reducing swelling is very important to managing lymphedema.
